Bank of New York Mellon »

Mineralys Therapeutics shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Mineralys Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2024-03-31 $634k 49k 12.91
2023-12-31 $404k 47k 8.60
2023-09-30 $385k 40k 9.51
2023-06-30 $686k 40k 17.05
2023-03-31 $521k 33k 15.66